Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Beximco Pharma (BXP) Share Price

Price 37.50p on 04-06-2025 at 07:00:22
Change 0.00p 0%
Buy 40.00p
Sell 35.00p
Buy / Sell BXP Shares
Last Trade: Sell 9,600.00 at 36.80p
Day's Volume: 0
Last Close: 37.50p
Open: 37.50p
ISIN: US0885792061
Day's Range 37.50p - 37.50p
52wk Range: 20.00p - 40.00p
Market Capitalisation: £167m
VWAP: 0.00p
Shares in Issue: 446m

Beximco Pharma (BXP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 9,600 36.80p Ordinary
13:02:32 - 03-Jun-25
Buy* 10,000 39.00p Ordinary
11:27:19 - 03-Jun-25
Sell* 30,000 36.266p Ordinary
09:34:43 - 03-Jun-25
Sell* 4,520 36.00p Ordinary
11:21:15 - 30-May-25
Buy* 3,850 37.85p Ordinary
11:20:45 - 30-May-25
Buy* 5,000 37.745p Ordinary
11:15:14 - 30-May-25
Buy* 1,000 38.00p Ordinary
15:23:40 - 29-May-25
Buy* 13,449 37.12p Ordinary
12:32:49 - 29-May-25
Sell* 4,481 35.0155p Ordinary
10:48:30 - 28-May-25
Buy* 27,209 36.7333p Ordinary
12:01:06 - 27-May-25
See more Beximco Pharma trades

Beximco Pharma (BXP) Share Price History

Time period:
to
Date Open High Low Close Volume
3rd Jun 2025 (Tue) 37.00 38.00 37.00 37.50 49,654
2nd Jun 2025 (Mon) 37.00 37.00 37.00 37.00 0
30th May 2025 (Fri) 36.00 37.00 36.00 37.00 13,370
29th May 2025 (Thu) 36.00 36.00 36.00 36.00 14,449
28th May 2025 (Wed) 36.00 36.00 36.00 36.00 4,559
27th May 2025 (Tue) 36.00 36.00 36.00 36.00 54,418
26th May 2025 (Mon) 36.7333 36.7333 36.7333 36.7333 0
23rd May 2025 (Fri) 36.00 36.00 36.00 36.00 1,000
22nd May 2025 (Thu) 36.00 36.00 36.00 36.00 10,000
21st May 2025 (Wed) 36.00 36.00 36.00 36.00 245
20th May 2025 (Tue) 36.00 36.00 36.00 36.00 3,000
19th May 2025 (Mon) 36.00 36.00 36.00 36.00 16,094
16th May 2025 (Fri) 36.00 36.00 36.00 36.00 7,941
15th May 2025 (Thu) 36.00 36.00 36.00 36.00 1,000
14th May 2025 (Wed) 36.00 36.00 36.00 36.00 148,004
13th May 2025 (Tue) 36.00 36.00 36.00 36.00 4,666
12th May 2025 (Mon) 36.00 36.00 36.00 36.00 8,371
9th May 2025 (Fri) 36.00 36.00 36.00 36.00 0
8th May 2025 (Thu) 36.00 36.00 36.00 36.00 171,669
7th May 2025 (Wed) 36.00 36.00 36.00 36.00 0
6th May 2025 (Tue) 34.50 36.00 34.50 36.00 37,841
5th May 2025 (Mon) 34.00 34.00 34.00 34.00 0
See more Beximco Pharma price history

Beximco Pharma (BXP) Regulatory News

Date Source Headline
21st May 2025 3:18 pm RNS Update on BSEC Order
28th Apr 2025 7:00 am RNS Request of Extension to Publish Q3 Results
21st Mar 2025 3:51 pm RNS Response to media reports and update on BSEC order
6th Mar 2025 7:00 am RNS Update on BSEC order
30th Jan 2025 2:59 pm RNS Payment of Cash Dividend
29th Jan 2025 7:01 am RNS Board Changes
29th Jan 2025 7:00 am RNS Half Year Results 2024-25
14th Jan 2025 11:24 am RNS Board of Directors
30th Dec 2024 7:00 am RNS Annual General Meeting Statement
19th Nov 2024 7:00 am RNS AGM Notification
See more Beximco Pharma regulatory news

Beximco Pharma (BXP) Share News

IN BRIEF: Beximco denies "all media allegations of corruption"

21st Mar 2025 16:20

Beximco Pharmaceuticals PLC - Dhaka, Bangladesh-based producer of pharmaceutical ingredients - Releases statement, originally published on Wednesday in Bangladesh, denying allegations of corruption in the Covid-19 vaccine procurement process. Says these allegations circulated in the Bangladeshi media on Monday and Tuesday, following the launch of an anti-corruption commission investigation. Statement says Beximco "is deeply concerned and disappointed by the misleading and defamatory news [reports]", adding: "The company rejects these baseless allegations and protests the sensationalized and slanderous headlines, that not only tarnished corporate reputation as a globally known pharmaceutical manufacturer and exporter but also confused thousands of its valued shareholders, especially many foreign investors who currently hold more than 32% of company's shares." Claims that "several" media outlets "clearly attempted to malign Beximco Pharma". Furthermore, Beximco "firmly asserts that it conducted all transactions with necessary approvals from the regulatory authorities". "Says it reserves the right to take appropriate legal action against such defamatory reporting". Read More

Beximco Pharma petitions board appointments amid fraud allegations

14th Jan 2025 14:32

(Alliance News) - Beximco Pharmaceuticals Ltd on Tuesday said it had issued a petition against nine appointments to its board by the Bangladesh Securities and Exchange Commission. Read More

Beximco Pharmaceuticals says full court hearing set for October 28

2nd Oct 2024 12:12

(Alliance News) - Beximco Pharmaceuticals Ltd on Wednesday said the Bangladesh court has referred the company's appeal in its recent fraud case to a full-court hearing, which will take place on October 28. Read More

IN BRIEF: Beximco Pharma vice-chair arrested for ties to ousted PM

15th Aug 2024 11:28

Beximco Pharmaceuticals - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Confirms that Vice-Chair Salman Rahman was arrested by Dhaka police on Tuesday and will be held for 10 days while an investigation into alleged offences is carried out. Rahman was a private industry and investment advisor to deposed Bangladesh prime minister Sheikh Hasina, who fled the country earlier this month amid accusations of human rights abuses. Read More

IN BRIEF: Beximco Pharma says Bangladesh unrest reduced distribution

13th Aug 2024 13:44

Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Distribution of products was reduced in response to the recent civil unrest in Bangladesh, in the interest of employee safety, but it is now returning to normal levels. "The interim government of Bangladesh has indicated that it intends to address any ongoing unrest as a priority, and we expect to be able to resume normal distribution in the coming days," Beximco says. No significant damage was done to its manufacturing and distribution facilities, and the company says it doesn't expect the disruption to have a "material impact" on annual results. Read More

See more Beximco Pharma news
FTSE 100 Latest
Value8,792.01
Change4.99

Login to your account

Forgot Password?

Not Registered